Abstracts & Commentary
The recent JAMA Oncology study on the risks of using complementary medicine after a cancer diagnosis provided sensational headlines—but did it provide any legitimate conclusions about the place of integrative medicine in cancer care?
Benjamin Franklin famously said, “Early to bed and early to rise makes a man healthy, wealthy, and wise.” According to a new study on circadian rhythms and cancer risk, early to supper may be better health advice (the study does not address wealth and wisdom).
Prior research has shown that anti-Müllerian hormone (AMH) is elevated in women with polycystic ovary syndrome. A fascinating study discovers that AMH levels remain elevated during pregnancy and provides evidence of effects on fetal development.
In a recent clinical trial eggshell membrane (ESM) significantly improved exercise-related joint pain and stiffness, supporting reports that ESM has chondroprotective effects and underscoring its clinical potential for patients with inflammatory joint disease.
Study finds that placebo can improve symptoms of allergic rhinitis, while positive expectations can have beneficial effects on subjective well-being.
Certain women with high breast density who are at risk for breast cancer may benefit from daily consumption of green tea extract.
Turning empty urban lots into green spaces appears to improve nearby residents’ psychological wellbeing, according to a recent study. The depression-alleviating effects are even greater among those below the poverty line.
The Framingham Heart Study has collected data from thousands of participants since its inception in 1948, generating a vast amount of data. A recent study used data from a subset of participants to analyze associations between fructose-containing drinks and incidence of asthma. The results give practitioners even more reason to discourage consumption of beverages such as soda and apple juice.
Mistletoe extract is a widely used natural cancer therapy, typically as an adjunct to conventional therapy, but evidence suggests its benefits and safety vary according to route of administration. A phase I study set out to answer questions about the safety and tolerability of intravenously administered mistletoe.
Study finds that nanocurcumin is safe and may improve outcomes in patients with amyotrophic lateral sclerosis (ALS), especially in those with bulbar ALS.